Sumsuzzman D M, Wang Z, Langley JM, Moghadas SM, Real-world effectiveness of nirsevimab against respiratory syncytial virus disease in infants: A systematic review and meta-analysis, The Lancet Child & Adolescent Health 2025, 9: 393-403.
Du Z, Pandey A, Moghadas SM, Bai Y, Wang L, Matrajt L, Singer BH, Galvani AP, Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults, Nature Medicine 2025, 31(2): 647-652.
Moghadas SM, Shoukat A, Bawden CE, Langley JM, Singer BH, Fitzpatrick MC, Galvani AP. Cost-effectiveness of prefusion F protein-based vaccines against respiratory syncytial virus disease for older adults in the United States. Clinical Infectious Diseases. 2024, 78(5): 1328-1335.
Shoukat A, Abdollahi E, Galvani AP, Halperin SA, Langley JM, Moghadas SM, Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of respiratory syncytial virus disease among infants in Canada: A simulation study, The Lancet Regional Health - Americas 2023, 28: 100629.
Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, Galvani AP, The implications of silent transmission for the control of COVID-19 outbreaks, Proceedings of the National Academy of Sciences USA 2020, 117(30): 17513–17515.
For citation of our published studies, visit Google Scholar
Shoukat A, Espindola A, Röst G, Moghadas SM, How the interval between primary and booster vaccination affects long-term disease dynamics, Mathematical Biology and Biological Physics 2017, 60–71.
Charania N, Moghadas SM, Modelling the effects of booster dose vaccination schedules and recommendations for public health immunization programs: the case of Haemophilus influenzae serotype b, BMC Public Health 2017, 17: 705.
Najafi M,Laskowski M, de Boer PT, Williams E, Chit A, Moghadas SM, The effect of individual movements and interventions on the spread of influenza in long-term care facilities, Medical Decision Making 2017, 37: 871–881.
Smirnov A, Chowell-Puente G, deCamp L, Moghadas SM, Sheppard MJ, Improving epidemic size prediction through stable reconstruction of disease parameters by reduced iteratively regularized Gauss-Newton algorithm, Journal of Inverse and Ill-Posed Problems 2017, 25: 653–667.
Chowell G, Viboud C, Simonsen L, Moghadas SM, Characterizing the reproduction number of epidemics with early sub-exponential growth dynamics, Journal of the Royal Society Interface 2016, 13: 20160659.
Milwid R, Steriu A, Arino J, Heffernan J, Hyder A, Schanzer D, Gardner E, Haworth-Brockman M, Isfeld-Kiely H, Langley JM, Moghadas SM, Towards standardizing a lexicon of infectious disease modelling terms, Frontiers in Public Health 2016, 4: 213.
Xiao Y, Brauer F, Moghadas SM, Can treatment increase the epidemic size? Journal of Mathematical Biology 2016, 72: 343–361.
Chowell G, Hincapie-Palacio D, Ospina J, Pell B, Tariq A, Dahal S, Moghadas SM, Smirnova A, Simonsen L, Viboud C. Using phenomenological models to characterize transmissibility and forecast patterns and final burden of Zika epidemics, PLoS Currents Outbreaks 2016, ID 1.
Knipl D, Moghadas SM, Comparative dynamics of monovalent and bivalent vaccination for immunologically unrelated pathogens, Journal of Biological Systems 2016, 24: 91–115.
Kang M, Espindola AL, Laskowski M, Moghadas SM, A modelling framework for serotype replacement in vaccine-preventable diseases, BIOMAT Proceedings 2016, 54–66.